Business Context and Reporting Period
This Form 8-K is a current report filed by Yunhong Green CTI Ltd. (YHGJ) on April 24, 2025. The filing addresses a regulatory compliance issue regarding the company's listing status on The Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on stock price compliance rather than operational financial performance.
Material Changes
The primary material event is the extension of a compliance period with Nasdaq Listing Rule 5550(a)(2) (Minimum Bid Price Rule):
- Initial Notice: On October 21, 2024, Nasdaq notified the company of non-compliance due to the common stock failing to maintain a minimum closing bid price of $1.00 for 30 consecutive business days.
- First Grace Period: The initial 180-day period to regain compliance expired on April 21, 2025, without the company achieving the required price.
- Second Grace Period: On April 24, 2025, Nasdaq granted a second 180-day grace period, extending the deadline to October 19, 2025.
Outlook, Risks, and Management Commentary
Management intends to actively monitor the closing bid price and evaluate options to regain compliance. The company stated that if the deficiency is not cured during the second compliance period, it will effect a reverse stock split if necessary. Compliance will be achieved if the bid price closes at $1.00 per share or more for a minimum of 10 consecutive business days before the new deadline.
Investor Verification Checklist
- Verify the current trading price of YHGJ to assess the likelihood of meeting the $1.00 threshold within the new 180-day window.
- Monitor future filings for announcements regarding a potential reverse stock split if the price target is not met by October 19, 2025.
- Review the full text of the Nasdaq Notice (Exhibit 99.1) for any additional conditions or requirements not summarized in the 8-K.
- Check for any concurrent financial disclosures in other recent filings (e.g., 10-Q or 10-K) to understand the underlying business health driving the stock price.